Detalles de la búsqueda
1.
Cardiac effects of deferasirox in transfusion-dependent patients with myelodysplastic syndromes: TELESTO study.
Br J Haematol
; 204(5): 2049-2056, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38343073
2.
Role of Arterial Hypertension and Hypertension-Mediated Organ Damage in Cardiotoxicity of Anticancer Therapies.
Curr Heart Fail Rep
; 20(1): 56-62, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36696001
3.
Impact of bioprosthetic valve type on peri-procedural myocardial injury and mortality after transcatheter aortic valve replacement.
Heart Vessels
; 36(11): 1746-1755, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33963455
4.
Potential cardiac risk of immune-checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects.
Med Res Rev
; 38(5): 1447-1468, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29283446
5.
Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non-Small Cell Lung Cancer Patients.
Oncologist
; 23(8): 936-942, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29567824
6.
An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracycline.
J Transl Med
; 16(1): 295, 2018 10 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-30359253
7.
Ivabradine in Cancer Treatment-Related Left Ventricular Dysfunction.
Chemotherapy
; 63(6): 315-320, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30840967
8.
Potential of creatine or phosphocreatine supplementation in cerebrovascular disease and in ischemic heart disease.
Amino Acids
; 48(8): 1955-67, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-26795537
9.
Baseline cardio-oncologic risk assessment in breast cancer women and occurrence of cardiovascular events: The HFA/ICOS risk tool in real-world practice.
Int J Cardiol
; 349: 134-137, 2022 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34848212
10.
Cancer Patient With Unusual Dyspnea in the COVID-19 Era: Challenging Management of a Rare Cardiac Tumor.
JACC Case Rep
; 3(5): 823-828, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33723533
11.
Diversity of Cardiologic Issues in a Contemporary Cohort of Women With Breast Cancer.
Front Cardiovasc Med
; 8: 654728, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34660706
12.
BMI and acute kidney injury post transcatheter aortic valve replacement: unveiling the obesity paradox.
J Cardiovasc Med (Hagerstown)
; 22(7): 579-585, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34076605
13.
Early infections after successful transcatheter aortic valve replacement are associated with increased short- and long-term mortality: A single-center study.
Int J Cardiol
; 332: 48-53, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33785390
14.
How to Monitor Cardiac Complications of Immune Checkpoint Inhibitor Therapy.
Front Pharmacol
; 11: 972, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32676031
15.
Arterial hypertension in cancer: The elephant in the room.
Int J Cardiol
; 281: 133-139, 2019 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30718135
16.
Does the HFA/ICOS tool overestimate the risk of cardiovascular toxicities in oncologic patients scheduled to receive anti-VEGF agents?
J Cardiovasc Med (Hagerstown)
; 23(12): 809-810, 2022 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36349946
17.
A Score-Based Approach to 18F-FDG PET Images as a Tool to Describe Metabolic Predictors of Myocardial Doxorubicin Susceptibility.
Diagnostics (Basel)
; 7(4)2017 Oct 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-29072629
18.
Doxorubicin Effect on Myocardial Metabolism as a Prerequisite for Subsequent Development of Cardiac Toxicity: A Translational 18F-FDG PET/CT Observation.
J Nucl Med
; 58(10): 1638-1645, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28646013
19.
Cardiovascular risk profile and events before and after treatment with anti-VEGF drugs in the setting of a structured cardio-oncologic program.
Eur J Prev Cardiol
; 28(9): e38-e40, 2021 08 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32375549
20.
Proposal for a tailored stratification at baseline and monitoring of cardiovascular effects during follow-up in chronic phase chronic myeloid leukemia patients treated with nilotinib frontline.
Crit Rev Oncol Hematol
; 107: 190-198, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27823647